Medivir invites to a conference call on new clinical data and further studies with MIV-818

Corporate Breaking News

Home : Medivir invites to a conference call on new clinical data and further studies with MIV-818

Sep 16 2021	Medivir invites to a conference call on new clinical data and further studies with MIV-818
STOCKHOLM, Sept. 16, 2021 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) invites to a conference call on the supporting clinical data from the completed dose escalation section of the phase 1b study with MIV-818, presented today at the European Society for Medical Oncology (ESMO)...


Source:https://www.prnewswire.com:443/news-releases/medivir-invites-to-a-conference-call-on-new-clinical-data-and-further-studies-with-miv-818-301378359.html

Related News
» US FTC Retains Care Labeling Rule After Consultation » Airport Information Systems Market - Global Market Analysis & Forecast Model \|17000 + Technavio Reports